4//SEC Filing
Ogden Christopher 4
Accession 0001610717-25-000085
CIK 0001501989other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:33 PM ET
Size
4.7 KB
Accession
0001610717-25-000085
Insider Transaction Report
Form 4
Ogden Christopher
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-18$0.60/sh−8,551$5,122→ 201,026 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]Includes 155,821 RSUs.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001914523
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:33 PM ET
- Size
- 4.7 KB